NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,964,000 | -34.8% | 139,503 | -38.4% | 0.02% | -35.1% |
| Q1 2019 | $7,615,000 | +6.8% | 226,642 | +4.5% | 0.04% | +2.8% |
| Q4 2018 | $7,129,000 | -47.5% | 216,881 | -2.6% | 0.04% | -45.5% |
| Q3 2018 | $13,577,000 | +49.0% | 222,714 | +19.3% | 0.07% | +53.5% |
| Q2 2018 | $9,115,000 | -50.2% | 186,663 | +8.5% | 0.04% | -52.7% |
| Q1 2018 | $18,285,000 | +91325.0% | 172,081 | +10303.9% | 0.09% | – |
| Q4 2016 | $20,000 | +42.9% | 1,654 | +97.6% | 0.00% | – |
| Q3 2016 | $14,000 | -26.3% | 837 | -36.0% | 0.00% | – |
| Q2 2016 | $19,000 | +18.8% | 1,308 | +10.5% | 0.00% | – |
| Q1 2016 | $16,000 | – | 1,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |